Is it a Good Idea to Invest in ADMA Biologics (ADMA) Stock Now?

ADMA Biologics, Inc. (ADMA) markets plasma-derived biologics for the treatment of immune deficiencies and the prevention of certain infectious diseases. The company markets Bivigam (to treat primary humoral immunodeficiency), Asceniv (to treat primary immunodeficiency) and Nabi-HB (to treat and provide enhanced immunity against the hepatitis B virus).ADMA Biologics’ top line currently comprises sales of these three FDA-approved products. The company’s commercial specialty biologics product portfolio is witn ...